Iranian Journal of Neurology 2017. 16(2):.

Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis
Mahmood Moosazadeh, Ravanbakhsh Esmaeili, Mohammad Mehdi Nasehi, Ghasem Abedi, Mahdi Afshari, Fereshteh Farshidi, Motahareh Kheradmand




Familial, Multiple Sclerosis, Prevalence, Meta-analysis, Iran


Files DK, Jausurawong T, Katrajian R and Danoff R. Multiple sclerosis. Primary care. 2015; 42: 159-75.

Esposito F, Guaschino C, Sorosina M, et al. Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction. Neurology(R) neuroimmunology & neuroinflammation. 2015; 2: e129.

Mansouri B, Asadollahi S, Heidari K, et al. Risk factors for increased multiple sclerosis susceptibility in the Iranian population. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2014; 21: 2207-11.

Hollenbach JA and Oksenberg JR. The immunogenetics of multiple sclerosis: A comprehensive review. Journal of autoimmunity. 2015; 64: 13-25.

Nielsen NM, Westergaard T, Rostgaard K, et al. Familial risk of multiple sclerosis: a nationwide cohort study. American journal of epidemiology. 2005; 162: 774-8.

Marrosu M, Lai M, Cocco E, et al. Genetic factors and the founder effect explain familial MS in Sardinia. Neurology. 2002; 58: 283-8.

Kahana E. Epidemiologic studies of multiple sclerosis: a review. Biomedicine & pharmacotherapy. 2000; 54: 100-2.

Carton H, Vlietinck R, Debruyne J, et al. Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. Journal of Neurology, Neurosurgery & Psychiatry. 1997; 62: 329-33.

Ebers G, Koopman W, Hader W, et al. The natural history of multiple sclerosis: a geographically based study. Brain. 2000; 123: 641-9.

Hader WJ and Yee IM. The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan. Multiple sclerosis international. 2014; 2014.

Hashemilar M, Savadi Ouskui D, Farhoudi M, Ayromlou H and Asadollahi A. Multiple sclerosis in East-Azerbaijan, north west Iran. Neurology Asia. 2011; 16: 127-31.

Etemadifar M and Abtahi S-H. Multiple Sclerosis in Isfahan: past, present and future. International journal of preventive medicine. 2012; 3.

Moosazadeh M, Nekoei‐moghadam M, Emrani Z and Amiresmaili M. Prevalence of unwanted pregnancy in Iran: a systematic review and meta‐analysis. The International journal of health planning and management. 2014; 29: e277-e90.

Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Preventive medicine. 2007; 45: 247-51.

Ashtari F, Shaygannejad V, Heidari F and Akbari M. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran. Journal of Isfahan Medical School. 2011; 29.

Baghizadeh S, Sahraian MA and Beladimoghadam N. Clinical and demographic factors affecting disease severity in patients with multiple sclerosis. Iranian journal of neurology. 2013; 12: 1.

Danesh-Sani SA, Rahimdoost A, Soltani M, Ghiyasi M, Haghdoost N and Sabzali-Zanjankhah S. Clinical assessment of orofacial manifestations in 500 patients with multiple sclerosis. Journal of Oral and Maxillofacial Surgery. 2013; 71: 290-4.

Ghabaae M and Roostaeizadeh M. Epidemiology of multiple sclerosis in Tehran: a three year study. Tehran University Medical Journal (TUMJ). 2007; 65: 74-7.

Mazaheri S FM, Hossainzadeh A. Evaluation of clinical and epidemiologic features of patients with multiple sclerosis with early onset and comparison with the beginning of puberty. Yafteh. 2007; 9: 39-44. [In persian]

Payamani.F MM. Survey of Symptoms and Side Effects in Patients With Multiple Sclerosis. Mandish 2011; 2: 45-50. [In persian]

Pourmemari M, Rabie S, Bagheri H, Taghilo G and Eskandari F. Epidemiologic variables in multiple sclerosis patients in ZANJAN. Journal of Nursing and Midwifery Faculties Guilan Medical University 2011; 21: 1-6. [In persian]

Rezaali S, Khalilnezhad A, Moghadasi AN, Chaibakhsh S and Sahraian MA. Epidemiology of multiple sclerosis in Qom: Demographic study in Iran. Iranian journal of neurology. 2013; 12: 136-43.

A.A. R and M.S P. Descriptive cross Sectional Study of Clinical Manifestation and MRI Finding in 60 Multiple Sclerosis Patients Scientific Journal of Hamedan university of Medical Sciences and Health Services 2005; 12: 53-6. [In persian]

Saadatnia M, Etemadifar M and Maghzi AH. Multiple sclerosis in Isfahan, Iran. International review of neurobiology. 2007; 79: 357-75.

Taraghi Z, Ilali E, Abedini M, et al. Quality of life among multiple sclerosis patients. Iran Journal of Nursing. 2007; 20: 51-9. [In persian]

Kalanie H, Gharagozli K and Kalanie AR. Multiple sclerosis: report on 200 cases from Iran. Multiple sclerosis. 2003; 9: 36-8.

Saman-Nezhad B, Rezaee T, Bostani A, Najafi F and Aghaei A. Epidemiological characteristics of patients with multiple sclerosis in Kermanshah, Iran in 2012. J Mazandaran Univ Med Sci. 2013; 23: 97-101.

El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K and Khader Y. Multiple sclerosis in Jordan: a clinical and epidemiological study. Journal of neurology. 2006; 253: 1210-6.

Nagy Z, Bencsik K, Rajda C, et al. Epidemiology of familial multiple sclerosis in Hungary. Multiple Sclerosis. 2007.

Willer CJ, Dyment DA, Cherny S, et al. A genome-wide scan in forty large pedigrees with multiple sclerosis. Journal of human genetics. 2007; 52: 955-62.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.